Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 1

Results: 9

Acknowledgement to Referees.

Published in:: PharmacoEconomics, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s40273-023-01343-x
Publication type:: Article

Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 117, doi. 10.1007/s40273-023-01320-4

By:

Michaeli, Daniel Tobias;
Michaeli, Thomas

Publication type:

Article

Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 41, doi. 10.1007/s40273-023-01318-y

By:

Lannon, Melissa;
Duda, Taylor;
Mastrolonardo, Alexander;
Huang, Ellissa;
Martyniuk, Amanda;
Farrokhyar, Forough;
Xie, Feng;
Bhandari, Mohit;
Kalia, Suneil K.;
Sharma, Sunjay

Publication type:

Article

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 5, doi. 10.1007/s40273-023-01317-z

By:

Coughlan, Diarmuid;
Arisa, Oluwatomi;
Thomson, Katie;
Yu, Ge;
Pearson, Fiona;
Kernohan, Ashleigh;
Gonzalez-Moral, Sonia Garcia;
Wallace, Sheila;
Rice, Stephen

Publication type:

Article

Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 109, doi. 10.1007/s40273-023-01314-2

By:

Hatswell, Anthony J.;
Chaudhary, Mohammad A.;
Monnickendam, Giles;
Moreno-Koehler, Alejandro;
Frampton, Katie;
Shaw, James W.;
Penrod, John R.;
Lawrance, Rachael

Publication type:

Article

The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 11, doi. 10.1007/s40273-023-01313-3

By:

Hill-McManus, Daniel

Publication type:

Article

A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 19, doi. 10.1007/s40273-023-01312-4

By:

Antoniou, Marina;
Mateus, Céu;
Hollingsworth, Bruce;
Titman, Andrew

Publication type:

Article

Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 69, doi. 10.1007/s40273-023-01309-z

By:

Hafeez, Aneeka;
Cipriano, Lauren E.;
Kim, Richard B.;
Zaric, Gregory S.;
Schwarz, Ute I.;
Sarma, Sisira

Publication type:

Article

Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis.

Published in:

PharmacoEconomics, 2024, v. 42, n. 1, p. 91, doi. 10.1007/s40273-023-01306-2

By:

Morton, Jedidiah I.;
Marquina, Clara;
Lloyd, Melanie;
Watts, Gerald F.;
Zoungas, Sophia;
Liew, Danny;
Ademi, Zanfina

Publication type:

Article